Revvity | PKI - Assets


Revvity reported $12.05B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Align Technology USD 6.42B 103.41M Jun/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Danaher USD 92.37B 8.82B Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Laboratory Of America USD 18.53B 554.8M Jun/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
OraSure Technologies USD 360.55M 18.62M Jun/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pacific Biosciences Of California USD 751.85M 30.51M Jun/2026
Pharma Mar EUR 393.6M 8.34M Jun/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
Repligen USD 2.95B 19.41M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
Sartorius EUR 9.6B 270.6M Jun/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025
Waters USD 24.75B 220M Jun/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026